Literature DB >> 8313837

Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury.

U A Boelsterli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8313837     DOI： 10.3109/03602539308993981

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  8 in total

1.  Evidence for cellular protein covalent binding derived from styrene metabolite.

Authors:  Wei Yuan; Hua Jin; Jou-Ku Chung; Jiang Zheng
Journal:  Chem Biol Interact       Date:  2010-05-12       Impact factor: 5.192

Review 2.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

3.  Potential physiological effects of pharmaceutical compounds in Atlantic salmon (Salmo salar) implied by transcriptomic analysis.

Authors:  Miriam Hampel; Esteban Alonso; Irene Aparicio; James E Bron; Juan Luis Santos; John B Taggart; Michael J Leaver
Journal:  Environ Sci Pollut Res Int       Date:  2010-02-06       Impact factor: 4.223

Review 4.  In vitro analysis of metabolic predisposition to drug hypersensitivity reactions.

Authors:  R J Riley; J S Leeder
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

5.  The role of stress in the regulation of drug metabolizing enzymes in mice.

Authors:  M Konstandi; M Marselos; A M Radon-Camus; E Johnson; M A Lang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.569

6.  Evidence of alpha2-adrenoceptor involvement in B[alpha]P induction processes of drug-metabolizing enzymes: the effect of stress.

Authors:  M Konstandi; D Kostakis; E Johnson; M A Lang; M Marselos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.569

Review 7.  Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

Authors:  B Burchell; M W Coughtrie
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

8.  Novel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic Metabolites.

Authors:  Rumen Kostov; Jeffrey T-J Huang; Colin J Henderson; C Roland Wolf
Journal:  J Pharmacol Exp Ther       Date:  2017-10       Impact factor: 4.030
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.